As the rollout of the U.S. COVID-19 vaccine program continued and questions remained about how allocation can simultaneously reduce risk and inequity, Penn LDI convened the video series, COVID Vaccine Equity Research Dialogues (CoVEReD).
Hosted by Penn LDI Senior Fellows and vaccine policy experts Alison Buttenheim, PhD, MBA and Harald Schmidt, PhD, the series brought together top experts to discuss equitable vaccine distribution. View all CoVEReD episodes and accompanying newsletters below, and visit our COVID-19 focus area page to see our latest research on the ongoing pandemic.
CoVEReD Episodes
Reaching COVID Vaccine Equity:
Are We There Yet?
Can We Overcome Vaccine Barriers for Immigrants in the U.S. and Improve Access Globally?
When Everyone’s Eligible,
What Happens to Vaccine Equity?
(April 20, 2021)
Should Allocation Be Increased Where Cases Are Rising and Decreased Where Demand is Low?
What Does President Biden’s May 1 Deadline for Universal Eligibility Mean for Vaccine Equity?
What Does Vaccine Choice
Mean for Equity?
Should We Use Disadvantage Indices to
Allocate Vaccine Doses?